The rating assignment and affirmation are based on several factors, including Moody’s Investors Service’s expectation that Presence Health’s cash flow challenges in fiscal years 2016 and 2017 will result in liquidity contraction.
The outlook is negative, reflecting Presence Health’s ongoing operating pressure, which could materially weaken its balance sheet.
More articles on healthcare finance:
Oregon price report explains payer exodus from some counties
Slowing U.S. healthcare wage growth sparks inflation concerns
Anthem Blue Cross of Calif. to launch bundled payment program for cancer care
